diphenyldiselenide has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Huan, Y; Huang, K; Ji, W; Lei, L; Li, C; Liu, Q; Liu, S; Shen, Z; Sun, S; Wang, X; Zhou, J | 2 |
2 other study(ies) available for diphenyldiselenide and Diabetic Nephropathies
| Article | Year |
|---|---|
Diphenyl Diselenide Alleviates Tert-Butyl Hydrogen Peroxide-Induced Oxidative Stress and Lipopolysaccharide-Induced Inflammation in Rat Glomerular Mesangial Cells.
Topics: Animals; Anti-Inflammatory Agents; Benzene Derivatives; Diabetic Nephropathies; Hydrogen Peroxide; Hypoglycemic Agents; Inflammation; Interleukin-1beta; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Mesangial Cells; NF-E2-Related Factor 2; Organoselenium Compounds; Oxidative Stress; Rats; Reactive Oxygen Species; RNA, Messenger; Selenium; Superoxide Dismutase; tert-Butylhydroperoxide; Tumor Necrosis Factor-alpha | 2022 |
Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation.
Topics: Animals; Antioxidants; Benzene Derivatives; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dyslipidemias; Gene Expression Regulation; Glucose; Inflammation; Kelch-Like ECH-Associated Protein 1; Kidney; Lipid Metabolism; Male; MAP Kinase Signaling System; Models, Biological; NF-E2-Related Factor 2; NF-kappa B; Organoselenium Compounds; Oxidative Stress; Rats, Sprague-Dawley; Streptozocin | 2021 |